symbol,statement_type,period_end,line_item,value
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-3654349.178011
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.282407
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Normalized EBITDA,190374000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Total Unusual Items,-12940000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-12940000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,95928000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,13031000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,855072000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,EBITDA,177434000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,EBIT,164403000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Interest Income,-29973000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Interest Expense,29973000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Interest Income,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Normalized Income,105213650.821989
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,95928000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Total Expenses,1160077000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Diluted Average Shares,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Basic Average Shares,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Diluted EPS,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Basic EPS,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,95928000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,95928000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Income,95928000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Minority Interests,-538000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,96466000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Income Discontinuous Operations,0.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,96466000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Tax Provision,37964000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Pretax Income,134430000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,21222000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Special Income Charges,-12940000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Other Special Charges,12940000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Write Off,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-29973000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,29973000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Operating Income,156120000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Operating Expense,305005000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Other Operating Expenses,231118000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,13031000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,13031000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Selling General And Administration,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,General And Administrative Expense,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Gross Profit,461125000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Cost Of Revenue,855072000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Total Revenue,1316197000.0
ZENITHDRUG.NS,income,2024-03-31 00:00:00,Operating Revenue,1316197000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.266859
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Normalized EBITDA,102893000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Total Unusual Items,0.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,48804000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,13054000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,781213000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,EBITDA,102893000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,EBIT,89839000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Interest Income,-23272000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Interest Expense,23272000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Interest Income,1600000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Normalized Income,48804000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,48804000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Total Expenses,1067743000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,703000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Diluted Average Shares,17148800.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Basic Average Shares,17148800.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Diluted EPS,2.845913
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Basic EPS,2.845913
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,48804000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,48804000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Income,48804000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Minority Interests,4000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,48803000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Income Discontinuous Operations,0.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,48803000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Tax Provision,17764000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Pretax Income,66567000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,12392000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Special Income Charges,0.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Other Special Charges,
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Write Off,-744000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-23272000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,3649000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,23272000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,1600000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Operating Income,77448000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Operating Expense,286530000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Other Operating Expenses,223861000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,13054000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,13054000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Selling General And Administration,38366000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,2156000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,General And Administrative Expense,36210000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,703000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Gross Profit,363978000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Cost Of Revenue,781213000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Total Revenue,1145191000.0
ZENITHDRUG.NS,income,2023-03-31 00:00:00,Operating Revenue,1145191000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,124070.360199
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.289884
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Normalized EBITDA,76363000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Total Unusual Items,428000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,428000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,31382000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,13263000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,749787000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,EBITDA,76791000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,EBIT,63528000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Interest Income,-17172000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Interest Expense,19469000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Interest Income,5221000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Normalized Income,31078070.360199
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,31382000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Total Expenses,855752000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,51000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Diluted Average Shares,17148800.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Basic Average Shares,17148800.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Diluted EPS,1.829982
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Basic EPS,1.829982
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,31382000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,31382000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Income,31382000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Minority Interests,96000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,31286000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Income Discontinuous Operations,
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,31287000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Tax Provision,12772000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Pretax Income,44059000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,1000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Special Income Charges,428000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Other Special Charges,-428000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Write Off,0.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-17172000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,2924000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,19469000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,5221000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Operating Income,60798000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Operating Expense,105965000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Other Operating Expenses,41054000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,13263000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,13263000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Selling General And Administration,17236000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,1530000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,General And Administrative Expense,15706000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,51000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Gross Profit,166763000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Cost Of Revenue,749787000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Total Revenue,916550000.0
ZENITHDRUG.NS,income,2022-03-31 00:00:00,Operating Revenue,916550000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,-622379.109537
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,0.341779
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Normalized EBITDA,74046000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Total Unusual Items,-1821000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-1821000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,30292000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,12160000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,534642000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,EBITDA,72225000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,EBIT,60065000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Interest Income,-15212000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Interest Expense,14044000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Interest Income,612000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Normalized Income,31490620.890463
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,30292000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Total Expenses,670332000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,90000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Diluted Average Shares,17148800.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Basic Average Shares,17148800.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Diluted EPS,1.766421
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Basic EPS,1.766421
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,30292000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,30292000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Income,30292000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Minority Interests,0.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,30292000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Income Discontinuous Operations,
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,30292000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Tax Provision,15729000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Pretax Income,46021000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,528000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Special Income Charges,-1821000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Other Special Charges,
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Write Off,1821000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,-15212000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,1780000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,14044000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,612000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Operating Income,63685000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Operating Expense,135690000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Other Operating Expenses,55324000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,12160000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,12160000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Selling General And Administration,32645000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,6634000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,General And Administrative Expense,26011000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,90000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Gross Profit,199375000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Cost Of Revenue,534642000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Total Revenue,734017000.0
ZENITHDRUG.NS,income,2021-03-31 00:00:00,Operating Revenue,734017000.0
